RESÚMENES DICIEMBRE 2009

.

Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

2 - Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly

Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK

Drugs Aging. 2009;26(12):997-1012

 

3! - Increased Mortality in Bulimia Nervosa and Other Eating Disorders

Scott J. Crow, Carol B. Peterson, Sonja A. Swanson, Nancy C. Raymond, Sheila Specker, Elke D. Eckert, and James E. Mitchell

Am J Psychiatry 2009; 166:1342-1346

1! -  The future of drug development: advancing clinical trial design

John Orloff, Frank Douglas, Jose Pinheiro, Susan Levinson, Michael Branson, Pravin Chaturvedi, Ene Ette, Paul Gallo, Gigi Hirsch, Cyrus Mehta, Nitin Patel, Sameer Sabir, Stacy Springs, Donald Stanski, Matthias R. Evers, Edd Fleming, Navjot Singh, Tony Tramontin & Howard Golub

Nature Reviews Drug Discovery 8, 949-957 (December 2009)

 

1! - Lessons from 60 years of pharmaceutical innovation

Bernard Munos

Nature Reviews Drug Discovery 8, 959-968 (December 2009)

 

3! - Seizure Threshold in a Large Sample: Implications for Stimulus Dosing Strategies in Bilateral Electroconvulsive Therapy: A Report From CORE

Petrides, Georgios; Braga, Raphael J; Fink, Max; Mueller, Martina; Knapp, Rebecca; Husain, Mustafa; Rummans, Teresa; Bailine, Samuel; Malur, Chitra; O'Connor, Kevin; Kellner, Charles; for the CORE (Consortium for Research in ECT) Group

The Journal of ECT: December 2009 - Volume 25 - Issue 4 - pp 232-237

 

3 - Paroxetine increases brain-derived neurotrophic factor in postmenopausal women

Cubeddu A, Giannini A, Bucci F, Merlini S, Casarosa E, Pluchino N, Luisi S, Luisi M, Genazzani AR

Menopause. 2009 Nov 20. [Epub ahead of print]

 

3 - Fibromyalgia: An Overview

Daniel J. Clauw

The American Journal of Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S3-S13

3 - Diagnosis and Differential Diagnosis of Fibromyalgia

Don L. Goldenberg

The American Journal of Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S14-S21

3 - Pathophysiology of Fibromyalgia

Laurence A. Bradley

The American Journal of Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S22-S30

3 - Further Strategies for Treating Fibromyalgia: The Role of Serotonin and Norepinephrine Reuptake Inhibitors

Philip J. Mease

The American Journal of Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S44-S55

5 - Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis

Marianna Mazza, Marzia Lotrionte, Giuseppe Biondi-Zoccai, Antonio Abbate, Imad Sheiban, and Enrico Romagnoli

Journal of Psychopharmacology. First published on December 4, 2009

3 - Catatonia: Clinical Aspects and Neurobiological Correlates

Jessica Daniels

J Neuropsychiatry Clin Neurosci 21:371-380, Fall

3 - Sertraline Improves Executive Function in Patients With Vascular Cognitive Impairment

Donald R. Royall, Jeffrey A. Cordes, Gustavo Román, Angela Velez, Aaron Edwards, Jason S. Schillerstrom, and Marsha J. Polk

J Neuropsychiatry Clin Neurosci 21:445-454, Fall

GRATIS 3 - Clinical Aspects and Management of Fibromyalgia Syndrome

Yong-Yeow Chong, Beng-Yeong Ng

Ann Acad Med Singapore 2009;38:967-73

 

3 - Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms

Dombrovski, Alexandre Y; Mulsant, Benoit H; Ferrell, Robert E; Lotrich, Francis E; Rosen, Jules I; Wallace, Meredith; Houck, Patricia R; Mazumdar, Sati; Pollock, Bruce G

International Clinical Psychopharmacology: January 2010 - Volume 25 - Issue 1 - pp 37-45

 

3 - Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR

Holl, Anna K; Wilkinson, Leonora; Painold, Annamaria; Holl, Etienne M; Bonelli, Raphael M

International Clinical Psychopharmacology: January 2010 - Volume 25 - Issue 1 - pp 46-50

 

3 - Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

Cummings, Jeffrey L; Farlow, Martin R; Meng, Xiangyi; Tekin, Sibel; Olin, Jason T

Clinical Drug Investigation: 1 January 2010 - Volume 30 - Issue 1 - pp 41-49

 

5 - Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.

Irani J, Salomon L, Oba R, Bouchard P, Mottet N

Lancet Oncol. 2009 Dec 4. [Epub ahead of print]

 

3 - Neuroprotective actions of selective estrogen receptor modulators

Lydia L. DonCarlos, Iñigo Azcoitia and Luis M. Garcia-Segura

Psychoneuroendocrinology. Volume 34, Supplement 1, December 2009, Pages S113-S122

3 - Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal Neurons

Flaubert Tchantchou, Pascale N. Lacor, Zhiming Cao, Lixing Lao, Yan Hou, Changhai Cui, William L. Klein, Yuan Luo

Journal of Alzheimer's Disease. Volume 18, Number 4 / 2009: 787-798

 

3 - Memantine Inhibits Calpain-Mediated Truncation of GSK-3 Induced by NMDA: Implications in Alzheimer's Disease

Paloma Goñi-Oliver, Jesús Avila, Félix Hernández

Journal of Alzheimer's Disease. Volume 18, Number 4 / 2009: 843-848

 

5 - A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

S. Salloway, R. Sperling, S. Gilman, N. C. Fox, K. Blennow, M. Raskind, M. Sabbagh, L. S. Honig, R. Doody, C. H. van Dyck, R. Mulnard, J. Barakos, K. M. Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, M. Grundman, For the Bapineuzumab 201 Clinical Trial Investigators

NEUROLOGY 2009;73:2061-2070

4 - Atomoxetine Treatment for ADHD. Younger Adults Compared With Older Adults

Todd Durell, Lenard Adler, Timothy Wilens, Martin Paczkowski, Kory Schuh

Journal of Attention Disorders, Vol. 13, No. 4, 401-406 (2010)

5 - Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease. A Randomized Controlled Trial

Robert C. Green, Lon S. Schneider, David A. Amato, Andrew P. Beelen, Gordon Wilcock, Edward A. Swabb, Kenton H. Zavitz, for the Tarenflurbil Phase 3 Study Group

JAMA. 2009;302(23):2557-2564

 

3 - Association Between Attention-Deficit/Hyperactivity Disorder and Sleep Impairment in Adulthood: Evidence From a Large Controlled Study

Craig B. H. Surman, Joel J. Adamson, Carter Petty, Joseph Biederman, Deborah C. Kenealy, Madeleine Levine, Eric Mick, and Stephen V. Faraone

J Clin Psychiatry 2009;70(11):1523–1529

 

3! - Presenting ADHD Symptoms, Subtypes, and Comorbid Disorders in Clinically Referred Adults With ADHD

Timothy E. Wilens, Joseph Biederman, Stephen V. Faraone, MaryKate Martelon, Diana Westerberg, and Thomas J. Spencer

J Clin Psychiatry 2009;70(11):1557–1562

 

3 - Direct Agonist Activity of Tricyclic Antidepressants at Distinct Opioid Receptor Subtypes

Pierluigi Onali, Simona Dedoni and Maria C. Olianas

JPET January 2010 vol. 332 no. 1 255-265

 

3! - Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia

Hussien A. Al-Shamma, Christen Anderson, Emil Chuang, Remy Luthringer, Andrew J. Grottick, Erin Hauser, Michael Morgan, William Shanahan, Bradley R. Teegarden, William J. Thomsen and Dominic Behan

JPET January 2010 vol. 332 no. 1 281-290

 

3 - Excessive daytime sleepiness in psychiatric disorders: Prevalence, correlates and clinical significance

Chris J. Hawley, Tim M. Gale, Thanusha Sivakumaran, Sarita Paul, Venkat Raj Goud Kondan, Ako Farag and Jawad Shahzad

Psychiatry Research. Volume 175, Issues 1-2, 30 January 2010, Pages 138-141

 

3! - Principle standards and problems regarding proof of efficacy in clinical psychopharmacology

Hans-Jürgen Möller and Karl Broich

European Archives of Psychiatry and Clinical Neuroscience. Volume 260, Number 1 / February, 2010: 3-16

 

3! - Meta-analyses: a method to maximise the evidence from clinical studies?

Wolfgang Maier and Hans-Jürgen Möller

European Archives of Psychiatry and Clinical Neuroscience. Volume 260, Number 1 / February, 2010: 17-23

 

3! - Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

Hans-Jürgen Möller and Wolfgang Maier

European Archives of Psychiatry and Clinical Neuroscience. Volume 260, Number 1 / February, 2010: 25-39

 

5 - Effects of Hormone Therapy on Depressive Symptoms and Cognitive Functions in Women With Alzheimer Disease: A 12 Month Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Estradiol and Norethisterone

Valen-Sendstad, Arnhild; Engedal, Knut; Stray-Pedersen, Babill; Strobel, Carsten; Barnett, Liv; Meyer, Nicolay; Nurminemi, Minna; ADACT Study Group

American Journal of Geriatric Psychiatry: January 2010 - Volume 18 - Issue 1 - pp 11-20

 

3 - Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder

Silva, Hernán; Iturra, Patricia; Solari, Aldo; Villarroel, Juana; Jerez, Sonia; Jiménez, Marco; Galleguillos, Felipe; Bustamante, Maria Leonor

Psychiatric Genetics: February 2010 - Volume 20 - Issue 1 - pp 25-30

 

3 - The stability of DSM personality disorders over twelve to eighteen years

Gerald Nestadt, Chongzhi Di, J.F. Samuels, O.J. Bienvenu, I.M. Reti, P. Costa, William W. Eaton and Karen Bandeen-Roche

Journal of Psychiatric Research. Volume 44, Issue 1, January 2010, Pages 1-7

 

3 - Role of Antiepileptic Drugs as Preventive Agents for Migraine

Vikelis, Michail; Rapoport, Alan M

CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp 21-33

 

3! - Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors: A Study of Spontaneous Reporting

Pariente, Antoine; Sanctussy, Dina Joseph-Reinette; Miremont-Salamé, Ghada; Moore, Nicholas; Haramburu, Françoise; Fourrier-Réglat, Annie; on behalf of l'Association Française des Centres Régionaux de Pharmacovigilance (CRPV)

CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp 55-63

 

GRATIS (previo registro) 3 - Síndrome confusional (delirium) en el anciano

M. Lázaro-Del Nogal, J.M. Ribera-Casado

PSICOGERIATRÍA 2009; 1 (4): 209-221

 

3 - Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia

Andre Richter, Simone Grimm, Georg Northoff

Human Psychopharmacology: Clinical and Experimental. Volume 25 Issue 1, Pages 55 - 62

 

5 - Ginkgo biloba for Preventing Cognitive Decline in Older Adults. A Randomized Trial

Beth E. Snitz, Ellen S. O’Meara, Michelle C. Carlson, Alice M. Arnold, Diane G. Ives, Stephen R. Rapp, Judith Saxton, Oscar L. Lopez, Leslie O. Dunn, Kaycee M. Sink, Steven T. DeKosky, for the Ginkgo Evaluation of Memory (GEM) Study Investigators

JAMA. 2009;302(24):2663-2670

 

3 - Pharmacological Treatment of Fibromyalgia Syndrome: New Developments

Staud, Roland

Drugs: 1 January 2010 - Volume 70 - Issue 1 - pp 1-14

 

3 - Milnacipran: In Fibromyalgia

Chwieduk, Claudine M; McCormack, Paul L

Drugs: 1 January 2010 - Volume 70 - Issue 1 - pp 99-108

 

5 - A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression

Andrew D. Krystal, John R. Harsh, Ronghua R. Yang, Gregory A. Rippon, and D. Alan Lankford

J Clin Psychiatry.Online ahead of print: December 29, 2009

 

GRATIS 3! - Incidence and Course of Suicidal Ideation and Suicide Attempts in the General Population

Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Jacqueline Verdurmen, Hedda van’t Land,  Wilma Vollebergh, Aartjan Beekman

Can J Psychiatry. 2009;54(12):824–833

 

3 - Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimer's Disease

Rosanna Squitti, Carlo Salustri

Current Alzheimer Research. Volume 6 Issue 6: 476-487

3 - Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

David M. Marks, Manan J. Shah, Ashwin A. Patkar, Prakash S. Masand, Geun-Young Park, Chi-Un Pae

Current Neuropharmacology. Volume 7 Issue 4: 331-336

GRATIS 3! - 2010 Guide to Psychiatric Drug Interactions

Sheldon H. Preskorn, and David Flockhart

Primary Psychiatry. 2009;16(12):45-74

 

GRATIS 3 - Sleep in Adults With ADHD and the Effects of Stimulants

Thomas Roth, and Joyce Zinsenheim

Primary Psychiatry. 2009;16(12):32-37

 

 



Regresar a RESÚMENES DICIEMBRE 2009

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.